Too Old to Operate5d
Bilateral CRSwNP Linked to Unique Risks Versus Unilateral Cases
Bilateral versus unilateral cases of chronic rhinosinusitis with nasal polyps have notable clinical and laboratory ...
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
The probability of revision sinus surgery including removing nasal polyps is higher if the patient has asthma or is on ...
News Medical on MSN5d
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery: Study
The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on ...
Science Daily11d
Asthma and antibiotic use may predict nasal polyp recurrence after endoscopic sinus surgery
The register-based population study explored the probability of revision surgery and factors associated with it in individuals with chronic rhinosinusitis with nasal polyps who had undergone ...
HealthDay on MSN8d
Baseline Characteristics ID Risk for Recurrent Endoscopic Sinus Surgery
THURSDAY, Feb. 6, 2025 (HealthDay News) -- A few baseline characteristics can predict the need for recurrent endoscopic sinus ...
GSK's depemokimab gets EMA nod for asthma and nasal polyps
GSK plc (LSE/NYSE: GSK), a prominent pharmaceutical company with a market capitalization of $71.29 billion and currently ...
pulmonologyadvisor1d
Eosinophilic Asthma: Benralizumab Effective in Severe Disease
Severe eosinophilic is effectively treated with benralizumab, with especially good outcomes in patients with high BEC and high FeNO.
pharmaphorum2d
FDA says no to AZ's Fasenra for nasal polyp indication
AstraZeneca has failed in its bid to get US approval for its IL-5 inhibitor Fasenra as a treatment for chronic rhinosinusitis in people with nasal polyps, after the FDA rejected its marketing ...